Abstract : Simple Summary It has been a continuous effort to develop innovative targeted cancer treatments to overcome the non-specific toxicity associated with chemotherapy. Antibody-drug conjugates (ADCs) highlight the clinical benefits of specifically delivering drugs to cancer cells via targeting agents. Aptamers are high-affinity ligands that can be made synthetically and employed as targeting molecules in place of antibodies.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Xirui
Contact Xirui, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack